Copenhagen researchers identify cilia signaling hub linked to congenital heart defects

September 14, 2026 at 05:00 AM2 min

This digest was compiled by AI from multiple sources — links to the originals are below.

Researchers at the University of Copenhagen have identified a previously unknown cellular mechanism in primary cilia that is crucial for heart formation during embryonic development. The discovery links defects in this signaling hub to congenital heart disease, which affects roughly two in every 100 newborns worldwide.

Key Facts

Congenital heart disease affects roughly two out of every 100 newborns worldwide, making it one of the most common birth defects.
The newly identified mechanism operates within the primary cilium, a microscopic antenna-shaped structure on the surface of most cells.
Three proteins—TAK1, TAB2 and PKA-Cα—work together as a signaling hub inside the primary cilium.
Approximately 2.3 to 2.5 million newborns worldwide are affected by congenital heart disease each year, with an estimated 16 million people living with the condition as of 2023.
The study focuses on syndromic heart defects, which occur as part of a wider genetic syndrome.

Cellular Signaling Hub

The mechanism operates within the primary cilium, a microscopic antenna-shaped structure that extends from the surface of most cells in the body. Primary cilia help cells sense and interpret chemical signals from their surroundings, influencing decisions such as whether a cell divides, moves or dies. Researchers found that three proteins, TAK1, TAB2 and PKA-Cα, work together as a signaling hub inside this cellular antenna. Their activity appears to be important for the normal formation of the heart.

Congenital Heart Disease Burden

Congenital heart disease refers to structural abnormalities of the heart that arise during embryonic development. Approximately 2.3 to 2.5 million newborns worldwide are affected by congenital heart disease each year. An estimated 16 million people were living with congenital heart disease as of 2023, according to the World Heart Federation and Danish Heart Foundation. Some congenital heart defects occur as part of a wider genetic syndrome, classified as syndromic congenital heart disease, while isolated cases are termed non-syndromic. The current study focuses on syndromic heart defects.

Experimental Validation

To investigate the system, researchers combined genetic information from people with congenital heart defects with experiments involving zebrafish, human cells and mouse stem cells.